ArticlePharmaceutics2024

Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation

Serge M Stamm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.